These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 34504310)

  • 21. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease.
    McAlinden KD; Eapen MS; Lu W; Sharma P; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L585-L595. PubMed ID: 32726146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaping-associated acute respiratory distress syndrome.
    Sakla NM; Gattu R; Singh G; Sadler M
    Emerg Radiol; 2020 Feb; 27(1):103-106. PubMed ID: 31820270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaping-induced lung injury in a 21-year-old woman.
    Perrenoud A; Vetos D; Wabwire G
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.
    Villalba JA; Hilburn CF; Garlin MA; Elliott GA; Li Y; Kunitoki K; Poli S; Alba GA; Madrigal E; Taso M; Price MC; Aviles AJ; Araujo-Medina M; Bonanno L; Boyraz B; Champion SN; Harris CK; Helland TL; Hutchison B; Jobbagy S; Marshall MS; Shepherd DJ; Barth JL; Hung YP; Ly A; Hariri LP; Turbett SE; Pierce VM; Branda JA; Rosenberg ES; Mendez-Pena J; Chebib I; Rosales IA; Smith RN; Miller MA; Rosas IO; Hardin CC; Baden LR; Medoff BD; Colvin RB; Little BP; Stone JR; Mino-Kenudson M; Shih AR
    Am J Respir Crit Care Med; 2022 Oct; 206(7):857-873. PubMed ID: 35671465
    [No Abstract]   [Full Text] [Related]  

  • 25. E-cigarette or vaping product use-associated lung injury (EVALI) masquerading as COVID-19.
    Ganne N; Palraj R; Husted E; Shah I
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34301688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells.
    Middleton EA; Zimmerman GA
    Crit Care Clin; 2021 Oct; 37(4):777-793. PubMed ID: 34548133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaping-related lung injury.
    Smith ML; Gotway MB; Crotty Alexander LE; Hariri LP
    Virchows Arch; 2021 Jan; 478(1):81-88. PubMed ID: 33106908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI).
    Shinbashi M; Rubin BK
    Paediatr Respir Rev; 2020 Nov; 36():87-91. PubMed ID: 32653465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
    Sahebnasagh A; Saghafi F; Safdari M; Khataminia M; Sadremomtaz A; Talaei Z; Rezai Ghaleno H; Bagheri M; Habtemariam S; Avan R
    J Clin Pharm Ther; 2020 Dec; 45(6):1515-1519. PubMed ID: 32860252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung Biopsy Findings in Severe Pulmonary Illness Associated With E-Cigarette Use (Vaping).
    Mukhopadhyay S; Mehrad M; Dammert P; Arrossi AV; Sarda R; Brenner DS; Maldonado F; Choi H; Ghobrial M
    Am J Clin Pathol; 2020 Jan; 153(1):30-39. PubMed ID: 31621873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
    Blagev DP; Harris D; Dunn AC; Guidry DW; Grissom CK; Lanspa MJ
    Lancet; 2019 Dec; 394(10214):2073-2083. PubMed ID: 31711629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
    Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
    Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaping-Associated Lung Injury During COVID-19 Multisystem Inflammatory Syndrome Outbreak.
    Hassoun A; Brady K; Arefi R; Trifonova I; Tsirilakis K
    J Emerg Med; 2021 Apr; 60(4):524-530. PubMed ID: 33483200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury.
    Tabassum N; Zhang H; Stebbing J
    Cell Rep Med; 2020 Nov; 1(8):100145. PubMed ID: 33225317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.
    Habashi NM; Camporota L; Gatto LA; Nieman G
    J Appl Physiol (1985); 2021 Mar; 130(3):877-891. PubMed ID: 33444117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Tree-in-Bloom": Severe Acute Lung Injury Induced by Vaping Cannabis Oil.
    He T; Oks M; Esposito M; Steinberg H; Makaryus M
    Ann Am Thorac Soc; 2017 Mar; 14(3):468-470. PubMed ID: 28248584
    [No Abstract]   [Full Text] [Related]  

  • 37. E-Cigarettes, Vaping Devices, and Acute Lung Injury.
    Cobb NK; Solanki JN
    Respir Care; 2020 May; 65(5):713-718. PubMed ID: 32345762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cigarette or vaping product use-associated acute lung injury (EVALI) as a therapeutic problem in anaesthesiology and intensive care departments.
    Bizoń M; Maciejewski D; Kolonko J
    Anaesthesiol Intensive Ther; 2020; 52(3):219-225. PubMed ID: 32876409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaping-Related Acute Parenchymal Lung Injury: A Systematic Review.
    Jonas AM; Raj R
    Chest; 2020 Oct; 158(4):1555-1565. PubMed ID: 32442559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products.
    Kapandji N; Yvin E; Devriese M; de Margerie-Mellon C; Moratelli G; Lemiale V; Jabaudon M; Azoulay E; Constantin JM; Dumas G
    Am J Respir Crit Care Med; 2021 Aug; 204(3):359-362. PubMed ID: 34033529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.